We Wrote the Book on How to Approach Outbreaks Like COVID-19. See What We’ve Learned From Our Previous Experience

Rules for managing outbreaks were created long before COVID-19. For example, engaging the local community and understanding their norms are important when managing an outbreak.
How do we know?
Because we’ve been there, we’ve studied outbreaks, and we literally wrote a book on it.
Our expert team of infectious disease clinical research specialists have studied outbreaks such as H5N1, HIV, Zika and Ebola. Written by these industry veterans, this e-book includes eight key points based on lessons learned from the front lines. A few include:

blog archive

2020 WOCIP Annual Conference: Educating, Empowering and Elevating Women of Color in Pharma Worldwide

“Educate, Empower, Elevate!” was the theme for the most recent conference for Women of Color in Pharma (WOCIP), a nonprofit aiming to promote the development and advancement of women of color who are employed in the pharmaceutical industry. We asked FHI Clinical team members, Tafoya Hubbard and LaTonya Jones to share some thoughts about their experiences during the 2020 two-day virtual event.

Read More »

Working Together to Expand Clinical Trials in Africa

We were honored to be part of the important discussion in a recent webinar from the African Academy of Sciences — “Strengthening the African clinical trials regulatory and ethics environment” — about extending research to areas where FHI 360/FHI Clinical has worked for decades. Participants included representatives of the AAS, Bill & Melinda Gates Foundation, World Health Organization (WHO) Regional Office for Africa, Novartis and FHI Clinical.

Read More »

Share this post

Share on linkedin
Share on twitter
Share on facebook